Editor in Chief | Global
Querida Anderson previously was the online managing editor at Genetic Engineering & Biotechnology News (GEN), which started as a trade magazine 30 years ago with a focus on biotech tools. Over her seven years at the publication, Querida gave GEN an online voice and expanded its coverage to drug development and business analysis. She wrote news stories daily and assigned and edited multiple analytical feature stories and blogs a week. She is a published science writer and has produced science news stories for ABC and NBC. Querida also worked on a documentary for the Discovery Channel. She has a Master’s in Science, Health and Environmental Reporting from NYU. Querida majored in Physics at Mumbai University, where she graduated with honors.
Editor | New York
Surani Fernando first joined BioPharm Insight's London office as a drug development reporter in 2010 and has generated a number of market moving scoops and in-depth analyses on key therapeutic areas. She has also reported on drug reimbursement, regulatory affairs, patent litigation, M&A and business financing. Surani has covered academic and industry meetings in both Europe and the US where she has interviewed key opinion leaders and C-level executives and has also made TV appearances on CNBC and Sky News as an industry commentator. In November 2014, Surani became the Editor of BPI’s European new desk and moved to New York in September 2016 to lead the US team. Prior to her career in journalism she worked in clinical operations at CRO PAREXEL. She has a Bachelor of Medical Science and Master of Health Communication both from Sydney University, Australia.
Coverage: Pulmonary/respiratory disorders, Men's and women's health, Infectious disease including vaccines except HCV, HBV and HIV
Senior Reporter | New York
Alaric DeArment covers cancer drug development for BioPharm Insight. He served as associate editor of Drug Store News from 2008 to 2014, covering branded and generic drugs from development to distribution, retail and specialty pharmacy and regulatory affairs. In 2011-2012, he edited the book Contestation and Adaption: The Politics of National Identity in China. A native of Seattle, he graduated with honors with a bachelor degree in journalism from Ball State University and also lived in China from 2001-2004.
Coverage: Brain cancer, Hematological cancers, Sarcoma, Polycythemia vera, Myelodysplastic syndromes, Myelofibrosis
Reporter | New York
Manasi Vaidya has a Masters degree in biotechnology. After a stint in a research lab, she spent two years as correspondent in India for BioSpectrum, a publication focused on the Asian biotechnology industry. She then moved to the United States to pursue a Masters degree in Science, Health and Environmental Reporting at New York University. Manasi has reported primarily on topics that combine health and policy, and her work has appeared in Nature Medicine, Nautilus and Scienceline. Her coverage at BioPharm Insight focuses on cancer.
Coverage: Cervical cancer, Ovarian cancer, Endometrial cancer, Thoracic cancer, Kidney cancer, Bladder cancer, Breast cancer, Prostate cancer, Head & Neck cancer, Thyroid Cancer, HIV, Vaccines (excluding HCV, HBV), Allergies, Respiratory
Senior Editorial Analyst | New York
Amit Jolly is a healthcare analyst at BioPharm Insight. He was previously a management associate at Velos, a clinical trial management software company based in Fremont, California, where he was responsible for creating new and efficient clinical trial management software tools for large research organizations, such as the National Marrow Donor Program. Prior to Velos, Amit was a business development and IP consultant at specialty pharmaceutical company PediatRx, where he was involved with assessing in-licensing opportunities.
He has a B.Sc. in Biotechnology, with a concentration in Bioscience Policy and Management from Rutgers University and a Masters in Biotechnology from Columbia University. He is also fluent in Spanish and proficient in Hindi.
Editorial Analyst | New York
Kelly Lambrinos is a healthcare analyst at BioPharm Insight. Prior to joining BioPharm Insight, Kelly held a Researcher position at Innovative Science Solutions, a full-service scientific and strategic regulatory consulting firm. At Innovative Science Solutions Kelly was involved in assisting small and large pharmaceutical companies with FDA Advisory Committee meeting preparation, including the one that led to the first biosimilar approval in the US, as well as other medical advocacy projects.
Kelly has a BS in Biology from the University of Athens, Greece and earned a Master’s Degree in Biotechnology from Columbia University. Her Master’s thesis focused on comparing the established guidelines, approval rates and length of the approval process for Biologics between the US and EU. Kelly is fluent in Greek.
Editor, EMEA | London
Jennifer Smith-Parker joined BioPharm Insight in October 2009, covering healthcare policy and regulatory news in Washington, DC. After developing excellent sources and fostering a reputation for producing in-depth analyses, scoops and trend pieces, she has steadily risen in BPI’s ranks. She has attended conferences across the US and Europe and moderated BPI panels with industry leaders. Prior to BPI, she was associate news editor at FDA Week, covering FDA regulatory policy. She also worked at The Monitor newspaper in South Texas where she was awarded the Texas Medical Association’s Anson Jones journalism award for an article on breast cancer. Jennifer graduated from New York University with a BA with Honors in History and Journalism.
Coverage: Generics and biosimilars, EU/US regulatory and reimbursement
Senior Reporter | London
Hamish McDougall has a BSc in Neuroscience from the University of Sussex and is primarily covering the neuroscience indications for BioPharm Insight. Prior to joining us he was assistant commissioning editor for a well-known collection of biomedical journals at Expert Reviews, including Expert Review of Gastroenterology & Hepatology, Expert Review of Clinical Pharmacology and Expert Review of Respiratory Medicine.
Coverage: Neurology/CNS, Psychiatry, Muscular Dystrophy, Lung cancer, Pain
Reporter | London
Fiona Barry previously worked in France as a journalist at William Reed Business Media, covering global manufacturing, regulatory and outsourcing news for the biopharmaceutical industry. She has also reported on global food and beverage companies. Fiona holds an M.A. in English and a B.A. in English and Philosophy from Bristol University. She speaks English and French.
Coverage: Women's and men's health, Orphan/rare diseases, Contract services sector (CROs, CMOs, other service providers), Industry trends
Reporter | London
Reynald Castaneda, prior to moving to London, was a journalist for healthcare newspaper New Zealand Doctor, covering primary care health politics and medical research. He has a BSc in Biological Sciences from the University of Auckland and a postgraduate diploma in journalism from AUT University. Prior to venturing into journalism, Reynald worked as a laboratory technician for Massey University’s Institute of Molecular Biosciences.
Coverage: Infectious diseases including HBV and HCV, Dermatology, Liver diseases, Liver Cancer, Gastric cancer, Colon Cancer, Pancreatic cancer, Melanoma
Senior Editorial Analyst | London
Peter Murphy has a first-class honours BSc degree in Chemistry with Medicinal Chemistry from Newcastle University, UK. He was awarded the Wynne-Jones Book Prize for outstanding performance in this degree. He also undertook three years of medical school training before joining the BPI Healthcare Analyst team. Peter has obtained the CFA society’s Investment Management Certificate and is an associate member of the Chartered Institute for Securities and Investment.
Editorial Analyst | London
Supa Chantschool has a MSc degree in International Health Management from Imperial College London Business School, UK and a BSc in Biomedical Sciences from King's College London, UK. His team had won the yearly Business Plan Competition for a full vertically integrated medical tourism platform for the US in his MSc. Additionally he had completed a Pricing & Market Access project with a consultancy firm before joining BioPharm Insight's editorial analyst team.